SCHEMBL16092423

SCHEMBL16092423

CC(C)c1c(-c2ccc(S(C)(=O)=O)c(F)c2)[nH]c2c(C#N)cnn2c1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 11/20 0.34
▸ DPP4 P27487 1/20 0.33
▸ PLAT P00750 2/20 0.33
▸ KDM5C P41229 2/20 0.33
▸ KDM4C Q9H3R0 2/20 0.33
▸ KDM5B Q9UGL1 2/20 0.33
▸ PGR P06401 1/20 0.32
▸ CYP11B1 P15538 1/20 0.32
▸ CYP11B2 P19099 1/20 0.32
▸ CTSC P53634 1/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ KDM6B O15054 1/20 0.32
▸ KDM5D Q9BY66 1/20 0.32
▸ PHF8 Q9UPP1 1/20 0.32
▸ PIK3CD O00329 1/20 0.32
▸ PIK3CA P42336 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ PIK3CG P48736 1/20 0.32
▸ KDM4D Q6B0I6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16092509 0.88 KDM5A (0.38) KDM5APLATKDM5CKDM4CKDM5B
SCHEMBL16092530 0.84 GCK (0.38) KDM5APLATKDM5CKDM4CKDM5B
SCHEMBL16091921 0.83 KDM5A (0.40) KDM5APLATPGR
SCHEMBL16092425 0.83 CYP11B2 (0.39) KDM5APLATKDM5BPGRCYP11B2
SCHEMBL16092238 0.83 CSNK2A1 (0.39) KDM5APLATKDM5CKDM4CKDM5B
SCHEMBL17547835 0.83 FASN (0.41) KDM5AKDM5CKDM4CKDM5BKDM6B
SCHEMBL17549439 0.82 AR (0.40) PGR
SCHEMBL16092434 0.82 PLAT (0.38) KDM5APLATKDM5CKDM4CKDM5B
SCHEMBL16092255 0.81 KDM5B (0.42) KDM5APLATKDM5CKDM4CKDM5B
SCHEMBL16091923 0.81 PTK6 (0.35) DPP4PLATKDM4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
WO-2015135094-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2015-09-17 — — WO disclosed
WO-2014139326-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B KDM5A 1/4885DPP4 582/4885PLAT 4107/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B KDM5A 1/4885DPP4 582/4885PLAT 4107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback